RC 20-051A - Avet - Tetracycline - NYC - Consumer


URGENT: Voluntary Drug Recall


  

Description NDC Lot# Exp/Date
Tetracycline HCl 250 mg Cap 23155001701 H190666 7/31/2022
Tetracycline HCl 500 mg Cap 23155001801 G190609  6/30/2022
Tetracycline HCl 500 mg Cap 23155001801 G190610  6/30/2022
Tetracycline HCl 500 mg Cap 23155001801 G190611  6/30/2022
Tetracycline HCl 500 mg Cap 23155001801 L191027  11/30/2022
Tetracycline HCl 500 mg Cap 23155001801 L191028  11/30/2022
Tetracycline HCl 500 mg Cap 23155001801 K190953  10/31/2022
Tetracycline HCl 500 mg Cap 23155001801 K190952  10/31/2022


Avet Pharmaceuticals Inc. is initiating a voluntary recall of the following lots of Tetracycline HCl 250 mg and 500 mg capsules due to an out of specification result during long term stability testing. This recall is to the Consumer level. Affected NDC's and lots are identified. Affected product started shipping August 2019.

Consumers should contact their doctor for further guidance and potential change of treatment before they stop taking this drug product.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Contact:

Qualanex : Qualanex Customer Service 888-424-4341